42.33
price up icon0.57%   0.24
after-market アフターアワーズ: 42.33
loading
前日終値:
$42.09
開ける:
$42.22
24時間の取引高:
947.97K
Relative Volume:
0.84
時価総額:
$9.41B
収益:
$1.94B
当期純損益:
$72.70M
株価収益率:
29.19
EPS:
1.45
ネットキャッシュフロー:
$405.21M
1週間 パフォーマンス:
+0.57%
1か月 パフォーマンス:
+0.50%
6か月 パフォーマンス:
-5.98%
1年 パフォーマンス:
+1.73%
1日の値動き範囲:
Value
$42.04
$42.48
1週間の範囲:
Value
$40.35
$42.48
52週間の値動き範囲:
Value
$39.03
$47.44

Qiagen Nv Stock (QGEN) Company Profile

Name
名前
Qiagen Nv
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
5,800
Name
Twitter
@QIAGEN
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
QGEN's Discussions on Twitter

QGEN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
QGEN 42.33 9.41B 1.94B 72.70M 405.21M 1.45
TMO 516.10 196.16B 42.37B 6.14B 7.78B 15.26
DHR 235.05 167.17B 23.74B 3.89B 4.98B 7.93
A 132.06 37.94B 6.50B 1.41B 1.42B 3.82
IQV 197.60 35.86B 15.32B 1.41B 1.96B 5.95
IDXX 418.55 34.27B 3.84B 866.24M 792.60M 9.80

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-19 開始されました Wells Fargo Equal Weight
2023-12-13 開始されました Wolfe Research Peer Perform
2023-12-07 アップグレード Goldman Neutral → Buy
2023-09-12 開始されました Robert W. Baird Outperform
2023-05-23 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-10-18 開始されました Morgan Stanley Equal-Weight
2022-01-18 アップグレード DZ Bank Hold → Buy
2021-10-15 再開されました Cowen Market Perform
2021-10-14 開始されました Redburn Buy
2021-07-14 ダウングレード Kepler Buy → Hold
2021-06-03 開始されました Goldman Neutral
2020-10-06 再開されました BofA Securities Buy
2020-09-28 アップグレード Kepler Hold → Buy
2020-08-24 アップグレード Citigroup Neutral → Buy
2020-08-20 再開されました JP Morgan Overweight
2020-08-17 アップグレード Berenberg Hold → Buy
2020-08-14 アップグレード Deutsche Bank Hold → Buy
2020-08-14 アップグレード Exane BNP Paribas Neutral → Outperform
2020-03-04 ダウングレード Berenberg Buy → Hold
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-12-26 再開されました BofA/Merrill Underperform
2019-11-15 開始されました Stifel Hold
2019-11-14 アップグレード Evercore ISI In-line → Outperform
2019-11-14 アップグレード JP Morgan Underweight → Overweight
2019-11-14 アップグレード Kepler Reduce → Hold
2019-10-17 アップグレード Wolfe Research Peer Perform → Outperform
2019-10-09 ダウングレード Kepler Hold → Reduce
2019-10-08 ダウングレード Barclays Overweight → Equal Weight
2019-10-08 ダウングレード Deutsche Bank Buy → Hold
2019-10-08 ダウングレード JP Morgan Neutral → Underweight
すべてを表示

Qiagen Nv (QGEN) 最新ニュース

pulisher
Nov 21, 2024

Massachusetts Financial Services Co. MA Sells 79,145 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Nov 21, 2024
pulisher
Nov 21, 2024

Jennison Associates LLC Boosts Position in Qiagen (NYSE:QGEN) - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

QIAGEN NV : Jefferies is Neutral - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Qiagen (NYSE:QGEN) Stake Lowered by Nuance Investments LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

Qiagen (NYSE:QGEN) Shares Bought by Natixis Advisors LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

180,729 Shares in Qiagen (NYSE:QGEN) Purchased by Impax Asset Management Group plc - MarketBeat

Nov 16, 2024
pulisher
Nov 13, 2024

QGEN Collaborates With McGill University Centre: Stock to Gain? - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Victory Capital Management Inc. Has $117.33 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

What is William Blair's Estimate for Qiagen FY2024 Earnings? - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Crossmark Global Holdings Inc. Sells 12,133 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Pharmahungary Group participates in ambitious EU EVEREST Project - European Biotechnology News

Nov 13, 2024
pulisher
Nov 12, 2024

QIAGEN collaborates with McGill University to advance microbiome research - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

QIAGEN Partners with McGill to Target $1.8B Microbiome Market in Major Research Deal | QGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

QIAGEN NV : UBS reiterates its Neutral rating - Marketscreener.com

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $459M beats by $2.09M - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition of Qiage - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

Qiagen Reports Strong Q3 2024 Growth - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Deutsche Bank reaffirms its Buy rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN : Markets hailed the Q3 beat + the profitability upgrade - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Receives a Buy rating from Berenberg - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen (NYSE:QGEN) Shares Sold by Van ECK Associates Corp - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : UBS reaffirms its Neutral rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 06, 2024

Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN Q3 Earnings Surge: Sales Hit $502M, Boosts 2024 EPS Outlook | QGEN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

FDA clears fourth Qiagen test in 2024 - BioWorld Online

Nov 05, 2024
pulisher
Nov 05, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen Receives FDA Clearance Of Qiastat-Dx Meningitis/Encephalitis Panel To Support Emergency Diagnostics - XM

Nov 04, 2024
pulisher
Oct 31, 2024

Forsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Qiagen (QGEN) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Trims Position in Qiagen (NYSE:QGEN) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.

Oct 29, 2024
pulisher
Oct 29, 2024

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - Yahoo Finance

Oct 29, 2024

Qiagen Nv (QGEN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$240.17
price up icon 0.98%
$169.36
price up icon 0.88%
$136.99
price up icon 4.03%
diagnostics_research WAT
$368.50
price up icon 3.00%
diagnostics_research MTD
$1,196.82
price up icon 2.56%
$418.55
price down icon 0.01%
大文字化:     |  ボリューム (24 時間):